Connection

Jean-Jacques Tuech to Survival Rate

This is a "connection" page, showing publications Jean-Jacques Tuech has written about Survival Rate.
Connection Strength

0.111
  1. Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry. Ann Surg Oncol. 2019 Mar; 26(3):852-860.
    View in: PubMed
    Score: 0.017
  2. Total Pancreatectomy for Presumed Intraductal Papillary Mucinous Neoplasms: A Multicentric Study of the French Surgical Association (AFC). Ann Surg. 2018 11; 268(5):823-830.
    View in: PubMed
    Score: 0.016
  3. Well differentiated papillary peritoneal mesothelioma treated by cytoreduction and hyperthermic intraperitoneal chemotherapy-the experience of the PSOGI registry. Eur J Surg Oncol. 2019 03; 45(3):371-375.
    View in: PubMed
    Score: 0.016
  4. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups. Eur J Surg Oncol. 2018 09; 44(9):1378-1383.
    View in: PubMed
    Score: 0.016
  5. Fukuoka-Negative Branch-Duct IPMNs: When to Worry? A Study from the French Surgical Association (AFC). Ann Surg Oncol. 2018 Apr; 25(4):1017-1025.
    View in: PubMed
    Score: 0.016
  6. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours. Br J Cancer. 2017 Sep 26; 117(7):1017-1025.
    View in: PubMed
    Score: 0.015
  7. Resectable invasive IPMN versus sporadic pancreatic adenocarcinoma of the head of the pancreas: Should these two different diseases receive the same treatment? A matched comparison study of the French Surgical Association (AFC). Eur J Surg Oncol. 2017 Sep; 43(9):1704-1710.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.